GnarraMBehrGKitajewskiA, et al. History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis. World J Clin Pediatr. 2016;5:273-280.
2.
ShelmerdineSCRoebuckDJTowbinAJMcHughK.MRI of paediatric liver tumours: how we review and report. Cancer Imaging. 2016;16(1):21.
3.
LahdennePHeikinheimoM.Clinical use of tumor markers in childhood malignancies. Ann Med. 2022; 34(5):316-323.
4.
HeYLuHZhangL.Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:199-212.
5.
MonclairTBrodeurGMAmbrosPF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG task force report. J Clin Oncol. 2009;27:298-303.
6.
TwistCJNaranjoASchmidtML, et al. Defining risk factors for chemotherapeutic intervention in infants with stage 4S neuroblastoma: a report from Children’s Oncology Group Study ANBL0531. J Clin Oncol. 2018;37:115-124.
7.
MeanyHJ.Non-high-risk neuroblastoma: classification and achievements in therapy. Children. 2019;6:5.
8.
TasMLNagtegaalMKraalKCJM, et al. Neuroblastoma stage 4S: tumor regression rate and risk factors of progressive disease. Pediatr Blood Cancer. 2020;67(4):e28061.
